Loading stock data…
Elevance Health, Inc. (ELV)
$388.03-7.15 (-1.81%)
Market ClosedLast close Jun 29
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elevance Health, Inc. in the Healthcare sector is trading at $388.03 with a market capitalization of $85.0B. Wall Street consensus targets $418.67 (21 analysts), implying a +7.9% move over the next 12 months. The stock is currently 9% below its 52-week high of $426.98, remaining 14.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +7.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $50.18B↑ | $49.75B↓ | $50.71B↑ | $49.78B↑ | $48.89B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $2.66B↑ | $581.00M↓ | $1.76B↓ | $2.63B↓ | $3.14B |
| Net Income | $1.76B↑ | $547.00M↓ | $1.19B↓ | $1.74B↓ | $2.18B |
Peer Comparison
JNJUNHPFE
Fundamentals
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of heal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$84.97B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.67
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.77%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.94%
Volume
Today's trading volume
880,366
Recent News
2 Reasons to Like ELV (and 1 Not So Much)
Elevance Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.8%. The stock now trades at $395.55, marking a 13.5% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
How CenterWell Is Driving Humana's Growth Beyond Insurance
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Heartland Advisors, an investment management company, released its first-quarter 2026 investor letter for the “Heartland Opportunistic Value Equity Strategy”. A copy of the letter can be downloaded here. Improving market breadth was noted in the first quarter, but geopolitical instability in the Middle East disrupted this trend. Instead of speculating on the conflict’s duration or […]
Can Carelon Drive Elevance Health's Future Earnings Growth?
Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.
3 Large-Cap Stocks with Exciting Potential
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.